CHARACTERIZATION OF THE TRANSLOCATION OF PROTEIN-KINASE-C (PKC) BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA ECSTASY) IN SYNAPTOSOMES - EVIDENCE FOR A PRESYNAPTIC LOCALIZATION INVOLVING THE SEROTONIN TRANSPORTER(SERT)/

Citation
Hk. Kramer et al., CHARACTERIZATION OF THE TRANSLOCATION OF PROTEIN-KINASE-C (PKC) BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA ECSTASY) IN SYNAPTOSOMES - EVIDENCE FOR A PRESYNAPTIC LOCALIZATION INVOLVING THE SEROTONIN TRANSPORTER(SERT)/, Neuropsychopharmacology, 19(4), 1998, pp. 265-277
Citations number
65
Categorie Soggetti
Neurosciences,Psychiatry,"Pharmacology & Pharmacy
Journal title
Neuropsychopharmacology
ISSN journal
0893133X → ACNP
Volume
19
Issue
4
Year of publication
1998
Pages
265 - 277
Database
ISI
SICI code
0893-133X(1998)19:4<265:COTTOP>2.0.ZU;2-I
Abstract
3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) is a substituted a mphetamine whose acute and long-term effects on the serotonin system a re dependent on an interaction with the 5-HT uptake transporter (SEAT) . Although much of the work dedicated to the study of this compound ha s focused on its ability to release monoamines, this drug has many imp ortant metabolic consequences on neurons and glial cells. The identifi cation of these physiological responses will help to bridge the gap th at exists in the information between the acute and neurotoxic effects of amphetamines. Substituted amphetamines have the ability to produce a long-term translocation of protein kinase C (PKC) in vivo, and this action may be crucial to the development of serotonergic neurotoxicity . Our earlier results suggested that PKC activation occurred through p re- and Postsynaptic mechanisms. Because the primary site of action of these drugs is the 5-HT transporter, we now expand on our previous re sults and attempt to characterize MDMA's ability to translocate PKC wi thin cortical 5-HT nerve terminals. In synaptosomes, MDMA produced a c oncentration-dependent increase in membrane-bound PKC (as measured by H-3-phorbol 12, 13 dibutyrate, H-3-PDBu) bindings sites. This response was abolished by cotreatment with the specific serotonin reuptake inh ibitor (SSRI), fluoxetine, but not by the 5-HT2A/2C antagonist, ketans erin. In contrast, full agonists to 5-HT1A and 5-HT2 receptors did not produce significant PKC translocation. MDMA-mediated PKC translocatio n also requires the presence of extracellular calcium ions. Using assa y conditions where extracellular calcium was absent prevented the in v itro activation of PKC by MDMA. Prolonged PKC translocation has been h ypothesized to contribute to the calcium-dependent neurotoxicity produ ced by substituted amphetamines. In addition, many physiological proce sses within 5-HT nerve terminals, including 5-HT reuptake and vesicula r serotonin release, ave susceptible to modification by PKC-dependent protein phosphorylation. Our results suggest that prolonged activation of PKC within the 5-HT nerve terminal may contribute to lasting chang es in the homeostatic function of 5-HT neurons, leading to the degener ation of specific cellular elements after repeated MDMA exposure. (C) 1998 American College of Neuropsychopharmacology. Published by Elsevie r Science Inc.